BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 37693622)

  • 1.
    Zhang L; Hsu JI; Braekeleer ED; Chen CW; Patel TD; Martell AG; Guzman AG; Wohlan K; Waldvogel SM; Urya H; Tovy A; Callen E; Murdaugh R; Richard R; Jansen S; Vissers L; de Vries BBA; Nussenzweig A; Huang S; Coarfa C; Anastas JN; Takahashi K; Vassiliou G; Goodell MA
    bioRxiv; 2024 Jan; ():. PubMed ID: 37693622
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Kahn JD; Miller PG; Silver AJ; Sellar RS; Bhatt S; Gibson C; McConkey M; Adams D; Mar B; Mertins P; Fereshetian S; Krug K; Zhu H; Letai A; Carr SA; Doench J; Jaiswal S; Ebert BL
    Blood; 2018 Sep; 132(11):1095-1105. PubMed ID: 29954749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PPM1D in Solid and Hematologic Malignancies: Friend and Foe?
    Zhang L; Hsu JI; Goodell MA
    Mol Cancer Res; 2022 Sep; 20(9):1365-1378. PubMed ID: 35657598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein phosphatase, Mg
    Husby S; Hjermind Justesen E; Grønbæk K
    Br J Haematol; 2021 Feb; 192(4):697-705. PubMed ID: 33616916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR129-1 regulates protein phosphatase 1D protein expression under hypoxic conditions in non-small cell lung cancer cells harboring a TP53 mutation.
    Yin HL; Xu HW; Lin QY
    Oncol Lett; 2020 Sep; 20(3):2239-2247. PubMed ID: 32782541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potentiality of Protein phosphatase Mg
    Yu M; Hu J; He D; Chen Q; Liu S; Zhu X; Li B
    J Clin Lab Anal; 2020 May; 34(5):e23171. PubMed ID: 31901183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of Ser/Thr phosphatase PPM1D induces neutrophil differentiation in HL-60 cells.
    Kamada R; Kudoh F; Yoshimura F; Tanino K; Sakaguchi K
    J Biochem; 2017 Oct; 162(4):303-308. PubMed ID: 28486685
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Milosevic J; Treis D; Fransson S; Gallo-Oller G; Sveinbjörnsson B; Eissler N; Tanino K; Sakaguchi K; Martinsson T; Wickström M; Kogner P; Johnsen JI
    Cancers (Basel); 2021 Nov; 13(23):. PubMed ID: 34885154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ppm1d truncating mutations promote the development of genotoxic stress-induced AML.
    Burocziova M; Danek P; Oravetzova A; Chalupova Z; Alberich-Jorda M; Macurek L
    Leukemia; 2023 Nov; 37(11):2209-2220. PubMed ID: 37709843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PPM1D activity promotes the replication stress caused by cyclin E1 overexpression.
    Martinikova AS; Stoyanov M; Oravetzova A; Kok YP; Yu S; Dobrovolna J; Janscak P; van Vugt M; Macurek L
    Mol Oncol; 2024 Jan; 18(1):6-20. PubMed ID: 37067201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting Mutant PPM1D Sensitizes Diffuse Intrinsic Pontine Glioma Cells to the PARP Inhibitor Olaparib.
    Wang Z; Xu C; Diplas BH; Moure CJ; Chen CJ; Chen LH; Du C; Zhu H; Greer PK; Zhang L; He Y; Waitkus MS; Yan H
    Mol Cancer Res; 2020 Jul; 18(7):968-980. PubMed ID: 32229503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Truncated PPM1D Prevents Apoptosis in the Murine Thymus and Promotes Ionizing Radiation-Induced Lymphoma.
    Martinikova AS; Burocziova M; Stoyanov M; Macurek L
    Cells; 2020 Sep; 9(9):. PubMed ID: 32927737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of Small Molecule Inhibitors of PPM1D Using a Novel Drug Discovery Platform.
    Jiang W; Shaw S; Rush J; Dumont N; Kim J; Singh R; Skepner A; Khodier C; Raffier C; Yan N; Schluter C; Yu X; Szuchnicki M; Sathappa M; Kahn J; Sperling AS; McKinney DC; Gould AE; Garvie CW; Miller PG
    bioRxiv; 2024 May; ():. PubMed ID: 38826457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PPM1D regulates p21 expression via dephoshporylation at serine 123.
    Cao R; Zhang J; Zhang M; Chen X
    Cell Cycle; 2015; 14(4):641-7. PubMed ID: 25590690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Somatic mosaic truncating mutations of PPM1D in blood can result from expansion of a mutant clone under selective pressure of chemotherapy.
    Kim B; Won D; Lee ST; Choi JR
    PLoS One; 2019; 14(6):e0217521. PubMed ID: 31242196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Silencing of PPM1D inhibits cell proliferation and invasion through the p38 MAPK and p53 signaling pathway in papillary thyroid carcinoma.
    Lu ZW; Wen D; Wei WJ; Han LT; Xiang J; Wang YL; Wang Y; Liao T; Ji QH
    Oncol Rep; 2020 Mar; 43(3):783-794. PubMed ID: 31922231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TP53 wild-type/PPM1D mutant diffuse intrinsic pontine gliomas are sensitive to a MDM2 antagonist.
    Xu C; Liu H; Pirozzi CJ; Chen LH; Greer PK; Diplas BH; Zhang L; Waitkus MS; He Y; Yan H
    Acta Neuropathol Commun; 2021 Nov; 9(1):178. PubMed ID: 34732238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of mutant PPM1D enhances DNA damage response and growth suppressive effects of ionizing radiation in diffuse intrinsic pontine glioma.
    Akamandisa MP; Nie K; Nahta R; Hambardzumyan D; Castellino RC
    Neuro Oncol; 2019 Jun; 21(6):786-799. PubMed ID: 30852603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PPM1D Mutations Drive Clonal Hematopoiesis in Response to Cytotoxic Chemotherapy.
    Hsu JI; Dayaram T; Tovy A; De Braekeleer E; Jeong M; Wang F; Zhang J; Heffernan TP; Gera S; Kovacs JJ; Marszalek JR; Bristow C; Yan Y; Garcia-Manero G; Kantarjian H; Vassiliou G; Futreal PA; Donehower LA; Takahashi K; Goodell MA
    Cell Stem Cell; 2018 Nov; 23(5):700-713.e6. PubMed ID: 30388424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PPM1D mutations silence NAPRT gene expression and confer NAMPT inhibitor sensitivity in glioma.
    Fons NR; Sundaram RK; Breuer GA; Peng S; McLean RL; Kalathil AN; Schmidt MS; Carvalho DM; Mackay A; Jones C; Carcaboso ÁM; Nazarian J; Berens ME; Brenner C; Bindra RS
    Nat Commun; 2019 Aug; 10(1):3790. PubMed ID: 31439867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.